Cable Hill Partners, LLC T2 Biosystems, Inc. Transaction History

Cable Hill Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$1.15 - $2.1 $17,250 - $31,500	-15,000 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$0.48 - $1.67 $12,000 - $41,750	-25,000 Reduced 62.5%	15,000 $19,000
Q1 2020 May 14, 2020	BUY	$0.28 - $1.23 $2,800 - $12,300	10,000 Added 33.33%	40,000 $26,000
Q4 2019 Feb 04, 2020	BUY	$0.96 - $2.94 $960 - $2,940	1,000 Added 3.45%	30,000 $35,000
Q3 2019 Oct 29, 2019	BUY	$0.58 - $3.01 $5,220 - $27,089	9,000 Added 45.0%	29,000 $73,000
Q2 2019 Aug 06, 2019	BUY	$1.47 - $3.16 $14,700 - $31,600	10,000 Added 100.0%	20,000 $34,000
Q1 2019 May 10, 2019	BUY	$2.56 - $4.48 $12,800 - $22,400	5,000 Added 100.0%	10,000 $26,000
Q4 2018 Feb 12, 2019	BUY	$2.98 - $6.86 $5,960 - $13,720	2,000 Added 66.67%	5,000 $15,000
Q2 2018 Aug 03, 2018	SELL	$5.97 - $9.58 $5,970 - $9,580	-1,000 Reduced 25.0%	3,000 $23,000
Q1 2018 Apr 20, 2018	SELL	$4.21 - $7.0 $4,210 - $7,000	-1,000 Reduced 20.0%	4,000 $26,000
Q4 2017 Feb 22, 2018	BUY	$3.73 - $4.6 $3,730 - $4,600	1,000 Added 25.0%	5,000 $23,000
Q3 2017 Oct 27, 2017	BUY	$3.9 - $6.78 $15,600 - $27,120	4,000	4,000 $17,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.